SG165168A1 - New adenoviruses, nucleic acids coding therefor and their use - Google Patents
New adenoviruses, nucleic acids coding therefor and their useInfo
- Publication number
- SG165168A1 SG165168A1 SG200703426-7A SG2007034267A SG165168A1 SG 165168 A1 SG165168 A1 SG 165168A1 SG 2007034267 A SG2007034267 A SG 2007034267A SG 165168 A1 SG165168 A1 SG 165168A1
- Authority
- SG
- Singapore
- Prior art keywords
- nucleic acids
- acids coding
- coding therefor
- adenoviruses
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/861—Adenoviral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/763—Herpes virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10248039 | 2002-10-15 | ||
| DE10322530 | 2003-05-19 | ||
| PCT/EP2003/005583 WO2003099859A2 (de) | 2002-05-27 | 2003-05-27 | Neue verwendung von adenoviren und dafür codierenden nukleinsäuren |
| DE10324085 | 2003-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG165168A1 true SG165168A1 (en) | 2010-10-28 |
Family
ID=32314683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG200703426-7A SG165168A1 (en) | 2002-10-15 | 2003-10-15 | New adenoviruses, nucleic acids coding therefor and their use |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8951772B2 (https=) |
| EP (1) | EP1554375B1 (https=) |
| JP (1) | JP4988199B2 (https=) |
| KR (1) | KR101123510B1 (https=) |
| AU (1) | AU2010257327C1 (https=) |
| CA (1) | CA2515650C (https=) |
| DK (1) | DK1554375T3 (https=) |
| MX (1) | MXPA05004074A (https=) |
| PL (1) | PL219321B1 (https=) |
| SG (1) | SG165168A1 (https=) |
| WO (1) | WO2004035616A2 (https=) |
| ZA (1) | ZA200502680B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003222427B8 (en) | 2000-11-17 | 2010-04-29 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same |
| US8071740B2 (en) | 2000-11-17 | 2011-12-06 | Vascular Biogenics Ltd. | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| CN100506284C (zh) | 2001-10-19 | 2009-07-01 | 脉管生物生长有限公司 | 多核苷酸构建体、药物组合物以及靶向的下调血管生成和抗癌的治疗方法 |
| JP5213298B2 (ja) | 2002-05-27 | 2013-06-19 | ホルム，ペル・ゾンネ | アデノウイルスおよびそれをコードしている核酸の新たな使用 |
| CA2546178A1 (en) | 2003-11-14 | 2005-06-09 | Per Sonne Holm | New use of adenovirus and nucleic acids coding therefor |
| EP1689446B1 (de) * | 2003-11-14 | 2015-01-07 | Per Sonne Holm | Neue adenoviren, dafür codierende nukleinsäuren und deren verwendung |
| US20090232800A1 (en) * | 2004-12-31 | 2009-09-17 | Per Sonne Holm | E1-minus adenoviruses and use thereof |
| SG158133A1 (en) * | 2004-12-31 | 2010-01-29 | Sonne Holm | Method for reversing multiple resistance in animal cells |
| KR100747646B1 (ko) | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
| WO2012022496A2 (en) | 2010-08-19 | 2012-02-23 | Per Sonne Holm | Method for killing tumor stem cells |
| KR20210031852A (ko) * | 2018-03-05 | 2021-03-23 | 클리니쿰 레히츠 데어 이자르 데어 테크니쉔 우니베르지테트 뮌헨 | 종양 세포 붕괴성 아데노바이러스와 cdk4/6 억제제의 조합물에 의한 종양의 치료 |
| AU2019294294A1 (en) | 2018-06-25 | 2021-02-11 | Fondazione Telethon Ets | Gene therapy |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998046779A1 (en) * | 1997-04-14 | 1998-10-22 | Genzyme Corporation | Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
| WO2001070951A2 (de) * | 2000-03-23 | 2001-09-27 | Max-Delbrück-Centrum für Molekulare Medizin | Mittel zur diagnose und therapie viraler erkrankungen |
| WO2002053711A2 (de) * | 2000-12-28 | 2002-07-11 | Per Sonne Holm | Verwendung des transkriptionsfaktors yb-1 in adenoviralen systemen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE178490T1 (de) * | 1993-02-16 | 1999-04-15 | Onyx Pharmaceuticals | Cytopathische viren zur therapie und prophylaxe der neoplasie |
| US5998205A (en) * | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US6254862B1 (en) * | 1997-03-03 | 2001-07-03 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| AU2002235141A1 (en) * | 2000-11-27 | 2002-06-03 | Geron Corporation | Glycosyltransferase vectors for treating cancer |
| US20030095989A1 (en) * | 2000-12-18 | 2003-05-22 | Irving John M. | Chimeric cytolytic viruses for cancer treatment |
| US20030138405A1 (en) * | 2001-04-17 | 2003-07-24 | Juan Fueyo | Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
-
2003
- 2003-10-15 MX MXPA05004074A patent/MXPA05004074A/es active IP Right Grant
- 2003-10-15 KR KR1020057006313A patent/KR101123510B1/ko not_active Expired - Fee Related
- 2003-10-15 CA CA2515650A patent/CA2515650C/en not_active Expired - Fee Related
- 2003-10-15 US US10/531,366 patent/US8951772B2/en not_active Expired - Lifetime
- 2003-10-15 PL PL376573A patent/PL219321B1/pl unknown
- 2003-10-15 WO PCT/EP2003/011427 patent/WO2004035616A2/de not_active Ceased
- 2003-10-15 EP EP03753560.6A patent/EP1554375B1/de not_active Expired - Lifetime
- 2003-10-15 JP JP2005501293A patent/JP4988199B2/ja not_active Expired - Lifetime
- 2003-10-15 DK DK03753560.6T patent/DK1554375T3/en active
- 2003-10-15 SG SG200703426-7A patent/SG165168A1/en unknown
-
2005
- 2005-04-01 ZA ZA2005/02680A patent/ZA200502680B/en unknown
-
2010
- 2010-12-20 AU AU2010257327A patent/AU2010257327C1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998046779A1 (en) * | 1997-04-14 | 1998-10-22 | Genzyme Corporation | Adenoviral vectors comprising a modified e4 region but retaining e4orf3 |
| WO2001070951A2 (de) * | 2000-03-23 | 2001-09-27 | Max-Delbrück-Centrum für Molekulare Medizin | Mittel zur diagnose und therapie viraler erkrankungen |
| WO2002053711A2 (de) * | 2000-12-28 | 2002-07-11 | Per Sonne Holm | Verwendung des transkriptionsfaktors yb-1 in adenoviralen systemen |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200502680B (en) | 2005-11-30 |
| US20060057113A1 (en) | 2006-03-16 |
| KR20050061530A (ko) | 2005-06-22 |
| EP1554375B1 (de) | 2018-08-22 |
| EP1554375A2 (de) | 2005-07-20 |
| KR101123510B1 (ko) | 2012-04-12 |
| JP4988199B2 (ja) | 2012-08-01 |
| US8951772B2 (en) | 2015-02-10 |
| WO2004035616A3 (de) | 2004-05-27 |
| CA2515650C (en) | 2019-10-01 |
| AU2010257327C1 (en) | 2012-02-16 |
| PL376573A1 (pl) | 2006-01-09 |
| AU2010257327A1 (en) | 2011-01-13 |
| PL219321B1 (pl) | 2015-04-30 |
| DK1554375T3 (en) | 2018-12-17 |
| CA2515650A1 (en) | 2004-04-29 |
| MXPA05004074A (es) | 2005-09-20 |
| JP2006518589A (ja) | 2006-08-17 |
| WO2004035616A2 (de) | 2004-04-29 |
| AU2010257327B2 (en) | 2011-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69916591T2 (de) | Hochzähe, hochfeste amorphe zirkoniumlegierung | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| TR200100056T2 (tr) | Nörotrofik faktörler | |
| SG165168A1 (en) | New adenoviruses, nucleic acids coding therefor and their use | |
| FI970579L (fi) | Andenovirus, joka käsittää glutationiperoksidaasia koodittavan geenin | |
| EP1218392A4 (en) | GENE THE PROTEINS ENCODE WHICH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER USE HAVE | |
| EP1074622A4 (en) | NEW POLYPEPTIDE, DNA CODING IT, AND ITS USE | |
| PE20399A1 (es) | Muteina ob | |
| EP1104771A4 (en) | NEW POLYPEPTIDES, cDNA encoding THEREOF AND USE THEREOF | |
| DE69930370D1 (de) | Testisspezifische, menschliche proteinase, svph1-8 | |
| AU8953401A (en) | A novel polypeptide, a human protein 16.83 ftsh and the polynucleotide encoding the polypeptide | |
| NO20024029D0 (no) | Nytt protein og gen som koder for proteinet | |
| AU5300999A (en) | Novel protein, gene encoding the same and utilization thereof | |
| AU8948301A (en) | A novel polypeptide, a human splicing protein 10.56 and the polynucleotide encoding the polypeptide | |
| DZ2803A1 (fr) | Polypeptide de la protéine c humaine. | |
| AU8948801A (en) | A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide | |
| ZA200409367B (en) | Novel use of adenoviruses and nucleic acids coding therefore. | |
| AU9364501A (en) | A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide | |
| AU2002210329A1 (en) | A novel polypeptide, a human ehd protein 12.1 and the polynucleotide encoding the polypeptide | |
| AU1660000A (en) | The polypeptide dream, used as CA2+ions-dependent transcriptional regulator and its gene coding therefor | |
| AU9362301A (en) | A novel polypeptide, a human apoptosis relative protein 9.46 and the polynucleotide encoding the polypeptide | |
| AU8951501A (en) | A novel polypeptide, a human tumor suppressor factor 11.77 and the polynucleotide encoding the polypeptide | |
| AU2003227428A8 (en) | Novel proteins and dnas encoding the same | |
| ES1038670Y (es) | Embarcacion. | |
| MXPA03000385A (es) | Proteina de aglomerante extracelular. |